| dc.description.abstract |
Background: HIV and non-communicable diseases (NCDs) comorbidities, particularly
hypertension, diabetes mellitus and cardiovascular diseases, are major public health concerns
worldwide, especially in hard burden regions like sub-Saharan Africa. Mortality due to non
communicable diseases has been rising and now account for the majority of deaths in people
living with HIV. However, the available evidence is primarily at the national or localized study
level, highlighting the need for pooled evidence on the range of NCDs to better understand the
magnitude of the problem and inform policy measures.
Objective: To estimate the pooled prevalence and summarize effect size of factors associated
with hypertension, diabetes, and cardiovascular diseases comorbidities among people living with
HIV in sub-Saharan Africa.
Method: This systematic review and meta-analysis were conducted following the
recommendation of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis
guidelines. We included cross-sectional, case-control, and cohort studies that reported prevalence
estimates for hypertension, diabetes, and cardio-vascular disease and the corresponding
associated factors among peoples living with HIV. Key terms and initial search strings, further
enhanced by an expert librarian, were used to conduct a comprehensive literature search in major
databases, including PubMed, EMBASE, Web of Science, and Scopus. The title/abstract
screening, full text review, quality assessment, and data extraction processes were conducted in
Covidence systematic review software: https://www.covidence.org. This study used a random
model to pool effect estimates due to significant between study heterogeneity. Subgroup,
sensitivity, and meta-regression were conducted as needed. All statistical tests were declared
significant at P-value<0.05. The protocol of this systematic review and meta-analysis was
registered in the International Prospective Register of Systematic Reviews (PROSPERO) with
registration
number
CRD42024508838
(https://www.crd.york.ac.uk/prospero/display_record.php).
Result: This meta-analysis included 99 primary studies from 16 countries, with a total of
499,351 participants. The regional distribution of the studies was: Eastern Africa (n=49),
Southern Africa (n=30), West Africa (n=12), and Central Africa (n=8). The pooled prevalences
were 19% for hypertension (95% CI: 18, 21; I2, 99.2%, P-value=0.0001), 5% for diabetes (95%
CI: 4, 7; I2, 98.2%, P-value=0.0001) and 5% for cardiovascular disease (95% CI: 1,13 I2, 99.5%,P-value=0.0001). The pooled effect estimates of factors associated with these outcomes were:
age (hypertension: AOR= 4.15; 95% CI: 2.77, 6.21; I2, 97.7%, P-value=0.0001, diabetes
mellitus: AOR= 2.37, 95% CI: 1.82,3.08; I2, 92.2%, P-value=0.0001); ART-duration
(hypertension: AOR = 1.9, 95% CI: 1. 36, 2.65; I2, 93.6%, P-value=0.0001, diabetes mellitus:
AOR= 4.63, 95% CI: 1. 60, 13.43; I2, 95.7% P-value=0.0001). Additionally, BMI (AOR=1.68,
95% CI: 1.49, 1.89; I2, 95.2%, P-value=0.0001), DM comorbidity (AOR=3.3 95% CI: 2.1,5.19)
I2, 81.7% P-value=0.0001) and male gender (AOR=, 1.42 95% CI: 1.26, 1.60; I2,80% P
value=0.0001) were associated with hypertension. Hypertension co-morbidity among adults
living with HIV also increased the risk of developing diabetes mellitus (AOR = 3.74, 95% CI: 2.
42 to 5.78; I2, 1% P-value=0.996).
Conclusion and recommendation: This meta-analysis reveals a significant prevalence of NCD
comorbidities among adults living with HIV, threatening quality of life and increasing mortality
and reversing gains from ART. Those communicated disease was associated with age, body
mass index, ART-duration, comorbidity and being male. The findings suggested interventional
strategies to life style changes to address the significant factors. We recommend age-appropriate
interventions, lifestyle modifications, gender-based risk stratification, and tailored ART regimens
to minimize risks. Additionally, integrating routine NCD screening into HIV care is crucial for
early detection and management, improving long-term outcomes for individuals living with HIV. |
en_US |